基本信息
views: 156

Bio
主要从事抗炎免疫药理学研究工作,研究方向包括:1)基于代谢组学的类风湿性关节炎和炎症性肠病的病理机制研究;2)中药活性成分与内源性活性物质改善免疫性炎症的作用机制和体内过程,开发新型治疗药物。主持过“重大新药创制”科技重大专项、国家自然科学基金、国家新药基金、高校博士点基金等国家级和省部级课题10余项,企业合作项目30余项。以通讯作者/第一作者在Brit J Pharmacol、FASEB J、Cell Death Dis等期刊发表SCI论文130余篇,入选“爱思唯尔中国高被引学者(2020、2021年)”和“全球顶尖前10万科学家(全球学者库)”,获授权发明专利8项,转让抗关节炎和降血糖五类中药新药各1个(排名第二),2013年获江苏省教学成果二等奖1项(排名第一)。
Research Interests
Papers共 317 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Xuemei Gu, Fangfang Zhou, Mingming Jiang, Ming Lin,Yue Dai, Wei Wang, Zhongbo Xiong, Han Liu, Minyi Xu, Lei Wang
Scientific reportsno. 1 (2025): 6927-6927
Xi Zeng, Liefeng Zhang, Hong Lu, Xinru Xue, Ling Yang, Xiuling Yang, Zhuohui Liu, Xiaoying Cao,Yue Dai,Zhifeng Wei
British journal of pharmacology (2025)
Shui Qing Qu, Yan Liang, Shuo Qiu Deng,Yu Li,Yue Dai, Cheng, Tuo Liu, Lu Qi Wang,Li Na Chen,Yu Jie Li
Biomedical and environmental sciences BESno. 2 (2025): 206-218
Biochemical pharmacology (2025): 117023-117023
Food & function (2025)
Yingying Li,Huimin Jiang, Xinyi Li, Hui Zhu,Yue Dai,Jie Zhang, Yueyue Sun, Xiang Chu,Wen Ju,Mengdi Xu,Zhenyu Li,Lingyu Zeng,Kailin Xu,Jianlin Qiao
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGYno. 1 (2025): 136-143
Bei Tong,Yannong Dou,Ting Wang,Juntao Yu,Xin Wu,Qian Lu,Guixin Chou, Zhengtao Wang,Lingyi Kong,Yue Dai,Yufeng Xia
Toxicology and Applied Pharmacologypp.116948, (2024)
Neoplasia (2024): 100966-100966
International Immunopharmacology (2024): 112729-112729
Load More
Author Statistics
#Papers: 317
#Citation: 6897
H-Index: 45
G-Index: 62
Sociability: 6
Diversity: 4
Activity: 48
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn